Natural products targeting the PI3K-Akt-mTOR signaling pathway in cancer: A novel therapeutic strategy

D Tewari, P Patni, A Bishayee, AN Sah… - Seminars in cancer …, 2022 - Elsevier
Abstract The phosphatidylinositol 3-kinase (PI3K)-Akt and the mammalian target of
rapamycin (mTOR) represent two vital intracellular signaling pathways, which are …

Targeting PI3K/AKT/mTOR network for treatment of leukemia

J Bertacchini, N Heidari, L Mediani, S Capitani… - Cellular and molecular …, 2015 - Springer
Objective Increased activity of PI3K/AKT/mTOR pathway has been observed in a huge
number of malignancies. This pathway can function as a prosurvival factor in leukemia stem …

Acute myeloid leukemia, version 3.2019, NCCN clinical practice guidelines in oncology

MS Tallman, ES Wang, JK Altman… - Journal of the National …, 2019 - jnccn.org
Acute myeloid leukemia (AML) is the most common form of acute leukemia among adults
and accounts for the largest number of annual deaths due to leukemias in the United States …

Acute myeloid leukemia, version 3.2017, NCCN clinical practice guidelines in oncology

MR O'Donnell, MS Tallman, CN Abboud… - Journal of the National …, 2017 - jnccn.org
Acute myeloid leukemia (AML) is the most common form of acute leukemia among adults
and accounts for the largest number of annual deaths due to leukemias in the United States …

Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non …

F Ciceri, C Bonini, MTL Stanghellini… - The lancet …, 2009 - thelancet.com
Background Procedures to prevent severe graft-versus-host disease (GVHD) delay immune
reconstitution secondary to transplants of haploidentical haemopoietic stem cells for the …

Acute myeloid leukemia

MR O'Donnell, CN Abboud, J Altman… - Journal of the National …, 2012 - jnccn.org
Acute myeloid leukemia (AML) remains the most common form of acute leukemia among
adults and accounts for the largest number of annual deaths due to leukemias in the United …

[HTML][HTML] The phosphatidylinositol 3-kinase/Akt/mTOR signaling network as a therapeutic target in acute myelogenous leukemia patients

AM Martelli, C Evangelisti, F Chiarini, JA McCubrey - Oncotarget, 2010 - ncbi.nlm.nih.gov
Abstract The phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin
(mTOR) signaling axis plays a central role in cell proliferation, growth, and survival under …

ILC1s control leukemia stem cell fate and limit development of AML

Z Li, R Ma, S Ma, L Tian, T Lu, J Zhang… - Nature …, 2022 - nature.com
Type I innate lymphoid cells (ILC1s) are critical regulators of inflammation and immunity in
mammalian tissues. However, their function in cancer is mostly undefined. Here, we show …

Phosphoinositide 3-kinase/Akt signaling pathway and its therapeutical implications for human acute myeloid leukemia

AM Martelli, M Nyåkern, G Tabellini, R Bortul… - Leukemia, 2006 - nature.com
Abstract The phosphoinositide 3-kinase (PI3K)/Akt signaling pathway is crucial to many
aspects of cell growth, survival and apoptosis, and its constitutive activation has been …

mTOR regulates cell survival after etoposide treatment in primary AML cells

Q Xu, JE Thompson, M Carroll - Blood, 2005 - ashpublications.org
Acute myeloid leukemia cells have constitutive activation of phosphatidylinositol 3 (PI3)
kinase and require PI3 kinase activation for survival; however, the function of the PI3 kinase …